{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:20:48Z","timestamp":1790767248040,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["9K09613"],"award-info":[{"award-number":["9K09613"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012910","name":"National Defense Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012910","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bbrc.2021.07.033","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:55:42Z","timestamp":1626328542000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Eribulin induces tumor vascular remodeling through intussusceptive angiogenesis in a sarcoma xenograft model"],"prefix":"10.1016","volume":"570","author":[{"given":"Eiko","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-9609","authenticated-orcid":false,"given":"Keisuke","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Senoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiro","family":"Susa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ishizaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Rikitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.07.033_bib1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4065\/82.11.1409","volume":"82","author":"Skubitz","year":"2007","journal-title":"Sarcoma, Mayo Clin Proc"},{"key":"10.1016\/j.bbrc.2021.07.033_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1200\/JCO.2017.74.9374","article-title":"Contemporary sarcoma diagnosis, genetics, and genomics","volume":"36","author":"Schaefer","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2021.07.033_bib3","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/cncr.30191","article-title":"Chemotherapy for soft tissue sarcoma","volume":"122","author":"Ratan","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2021.07.033_bib4","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-14-3252","article-title":"Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent","volume":"21","author":"Dybdal-Hargreaves","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2021.07.033_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.critrevonc.2011.03.002","article-title":"Eribulin -- a review of preclinical and clinical studies","volume":"81","author":"Swami","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2021.07.033_bib6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bjc.2016.122","article-title":"In\u00a0vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab","volume":"114","author":"Ueda","year":"2016","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.bbrc.2021.07.033_bib7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/cas.12488","article-title":"Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models","volume":"105","author":"Funahashi","year":"2014","journal-title":"Canc. Sci."},{"key":"10.1016\/j.bbrc.2021.07.033_bib8","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/cas.13392","article-title":"Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models","volume":"108","author":"Ito","year":"2017","journal-title":"Canc. Sci."},{"key":"10.1016\/j.bbrc.2021.07.033_bib9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-19-0358","article-title":"Eribulin suppresses clear cell sarcoma growth by inhibiting cell proliferation and inducing melanocytic differentiation both directly and via vascular remodeling","volume":"19","author":"Nakai","year":"2020","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2021.07.033_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.2017.75.1941","article-title":"Synovial sarcoma: current concepts and future perspectives","volume":"36","author":"Stacchiotti","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2021.07.033_bib11","doi-asserted-by":"crossref","first-page":"117670","DOI":"10.1016\/j.lfs.2020.117670","article-title":"Intussusceptive angiogenesis as a key therapeutic target for cancer therapy","volume":"252","author":"Saravanan","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2021.07.033_bib12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/dvdy.20184","article-title":"Intussusceptive angiogenesis: its emergence, its characteristics, and its significance","volume":"231","author":"Burri","year":"2004","journal-title":"Dev. Dynam."},{"key":"10.1016\/j.bbrc.2021.07.033_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00441-003-0784-3","article-title":"Vascular remodeling by intussusceptive angiogenesis","volume":"314","author":"Djonov","year":"2003","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2021.07.033_bib14","first-page":"1013","article-title":"In\u00a0vitro and in\u00a0vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B","volume":"61","author":"Towle","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.07.033_bib15","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/cas.13637","article-title":"Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma","volume":"109","author":"Miki","year":"2018","journal-title":"Canc. Sci."},{"key":"10.1016\/j.bbrc.2021.07.033_bib16","doi-asserted-by":"crossref","first-page":"100054","DOI":"10.1016\/j.esmoop.2021.100054","article-title":"Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)","volume":"6","author":"De Angelis","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbrc.2021.07.033_bib17","doi-asserted-by":"crossref","first-page":"a006486","DOI":"10.1101\/cshperspect.a006486","article-title":"Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease","volume":"2","author":"Goel","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bbrc.2021.07.033_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10456-014-9428-3","article-title":"Intussusceptive angiogenesis: expansion and remodeling of microvascular networks","volume":"17","author":"Mentzer","year":"2014","journal-title":"Angiogenesis"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21010706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21010706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:40:55Z","timestamp":1762094455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21010706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":18,"alternative-id":["S0006291X21010706"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.07.033","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eribulin induces tumor vascular remodeling through intussusceptive angiogenesis in a sarcoma xenograft model","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}